Skip to Main Content

ManagedCareEye.com

This website is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Home
CE Activities
Faculty
Expert Updates
Outcomes
Resources

Retinopathy of Prematurity (ROP) –Management of an Infant Born at 30 Weeks Gestational Age in a Rural Area

December 12, 2023

FEATURING: Jeffrey Dunn, PharmD, MBA, Edward H. Wood, MD

← PayerTalkCE™Presents: Impact of An Aging US Population on Retinal Diseases Risk of Retinal Vein Occlusion (RVO) –52-Year-Old Male with a History of Poor Adherence to Hypertension and Dyslipidemia Therapy →

About Impact Education, LLC
Contact Us (IMPACT)
Mailing List (IMPACT)
Privacy Policy

Jointly provided by

Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.